Antigen-specific IgA B memory cell responses to Shigella antigens elicited in volunteers immunized with live attenuated Shigella flexneri 2a oral vaccine candidates.
about
Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans.Applying mathematical tools to accelerate vaccine development: modeling Shigella immune dynamicsShigella flexneri 3a outer membrane protein C epitope is recognized by human umbilical cord sera and associated with protective activityBroadly protective Shigella vaccine based on type III secretion apparatus proteins.Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica serovar Paratyphi A and S. Paratyphi B in humansShigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a.Self-adjuvanting bacterial vectors expressing pre-erythrocytic antigens induce sterile protection against malariaCirculating Gut-Homing (α4β7+) Plasmablast Responses against Shigella Surface Protein Antigens among Hospitalized Patients with Diarrhea.Clinical Trial of an Oral Live Shigella sonnei Vaccine Candidate, WRSS1, in Thai Adults.Progress and pitfalls in Shigella vaccine research.The human intestinal IgA response; burning questions.Recent progress towards development of a Shigella vaccine.Insights from natural infection-derived immunity to cholera instruct vaccine efforts.A randomized, placebo-controlled, double-blind Phase 2 trial comparing the reactogenicity and immunogenicity of a single ≥2x108 colony forming units [cfu] standard-dose versus a ≥2x109 cfu high-dose of CVD 103-HgR live attenuated oral cholera vaccinDiverse phosphorylation patterns of B cell receptor-associated signaling in naïve and memory human B cells revealed by phosphoflow, a powerful technique to study signaling at the single cell level.
P2860
Q34068059-9BC5A874-FAC0-430A-867D-8C9B58C9B377Q34669980-1C6D1005-31CA-45E8-9852-3EA14DED8D67Q34935297-F50B34B1-B8A1-4636-AC66-76C9254990C7Q35805439-0D2A93CB-C577-4E42-BF56-1AD13DC3EC1FQ36017715-CA04FA3F-CD89-4E92-8EB5-0FBFCBC2B6F3Q36920244-B77DD99C-4668-4A72-978A-B57DE532B1FCQ36981626-7310C6D6-11F2-4CAF-9D36-B439E72E32D2Q37067264-70CDEEC1-47F1-49F8-A793-433088A592CDQ37067290-C32B1DC3-0F45-4CD8-9AE4-62C697ECEF86Q37105553-F5F5514B-6B51-444B-9C96-968CA34D2A49Q38010705-0A9B5785-C71A-4B74-801F-434390F7B9C4Q38068954-3DADA7B7-A513-412C-A7C6-34C3B6977E27Q41426133-1ED56CB3-A964-4E07-A65A-834C66548142Q41986831-DFF96735-500C-4E8F-A4D6-E25FB8878358Q42421045-3F6465F5-0E53-4E2A-8453-9E5A1E2BB7E5
P2860
Antigen-specific IgA B memory cell responses to Shigella antigens elicited in volunteers immunized with live attenuated Shigella flexneri 2a oral vaccine candidates.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Antigen-specific IgA B memory ...... ri 2a oral vaccine candidates.
@ast
Antigen-specific IgA B memory ...... ri 2a oral vaccine candidates.
@en
Antigen-specific IgA B memory ...... ri 2a oral vaccine candidates.
@nl
type
label
Antigen-specific IgA B memory ...... ri 2a oral vaccine candidates.
@ast
Antigen-specific IgA B memory ...... ri 2a oral vaccine candidates.
@en
Antigen-specific IgA B memory ...... ri 2a oral vaccine candidates.
@nl
prefLabel
Antigen-specific IgA B memory ...... ri 2a oral vaccine candidates.
@ast
Antigen-specific IgA B memory ...... ri 2a oral vaccine candidates.
@en
Antigen-specific IgA B memory ...... ri 2a oral vaccine candidates.
@nl
P2093
P2860
P921
P1433
P1476
Antigen-specific IgA B memory ...... eri 2a oral vaccine candidates
@en
P2093
K L Kotloff
M B Sztein
M F Pasetti
M M Levine
W L Picking
P2860
P304
P356
10.1016/J.CLIM.2011.02.003
P50
P577
2011-03-08T00:00:00Z